We have been working with the NHS and pharmaceutical industry for over a decade, winning Critical Conversations™ through our prolific access to key decision-makers and an unrivalled understanding of complex healthcare systems.
With our insights, knowledge and experience, we are often asked for support communicating with the NHS, particularly with the delivery of Advanced Product Notifications (APNs). Being able to navigate the launch of a new or modified product whilst preparing the NHS for this change, at the right time, can feel challenging and we know we have the experience and knowledge to help.
APNs are vital when pharmaceutical companies have a legitimate need to update health professionals or other stakeholders with budgetary responsibility, regarding a change in the availability of a new medicine or other technology. This generates a need for early communication between the NHS and the pharmaceutical industry, particularly with regard to any expected developments that may impact the decisions along the way. To support the NHS, the pharmaceutical industry has a key role to play in ensuring this information is communicated as accurately and timely as possible.
Recognising the need for an even greater understanding and support for our clients, we partner with our colleagues at NeoSypher to translate key data into localised impacts in order to find true value in your proposition. Together, we have created an award-winning APN presentation tool to process the complex information and present it in an easily digestible format. We knew we needed a tool where our clients could easily export information and create bespoke presentations tailored to specific localities. With the ability to easily navigate between which Area Prescribing Committees (APCs) or the Primary Care Organisations (PCOs) your NHS customer is financially responsible for, our APN tool easily extracts hidden insights within your data and applies them to your APN to maximise your coverage.
It doesn’t stop there; with our unrivalled relationships across the NHS, we are also able to ensure that your APNs get to the right people as soon as possible while ensuring complete compliance within the ABPI code. We can give you the confidence and peace of mind that all appropriate healthcare systems will be made aware of the impact of your APN and are able to plan for it. As a combined force, our last APN was delivered personally to 95% of PCOs within six months for a new treatment in Parkinson’s Disease and we are consistently aiming for a minimum of 90% coverage. We pride ourselves on our ability to fuse our strengths across NeoHealthHub to ensure we deliver the best possible service for our clients. Guiding you through every step, we provide expert input into the design of the APN conversation all the way to the delivery of the APN to all PCOs and beyond into a successful product launch.
If you’re developing a new product that is expected to have a significant budgetary and/or service impact on the delivery of healthcare and are looking for the access and resources to deliver this notification, reach out to us at hello@neonavitas.com... we would love to help you.